Home
>
National Drug Code (NDC)
>
ZOLINZA
ZOLINZA - 0006-0568-40 - (vorinostat)
Drug Information of ZOLINZA
| Product NDC: | 0006-0568 |
| Proprietary Name: | ZOLINZA |
| Non Proprietary Name: | vorinostat |
| Active Ingredient(s): | 100 mg/1 & nbsp; vorinostat |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZOLINZA
| Product NDC: | 0006-0568 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021991 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20061006 |
Package Information of ZOLINZA
| Package NDC: | 0006-0568-40 |
| Package Description: | 120 CAPSULE in 1 BOTTLE (0006-0568-40) |
NDC Information of ZOLINZA
| NDC Code | 0006-0568-40 |
| Proprietary Name | ZOLINZA |
| Package Description | 120 CAPSULE in 1 BOTTLE (0006-0568-40) |
| Product NDC | 0006-0568 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | vorinostat |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20061006 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | VORINOSTAT |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] |
